149 related articles for article (PubMed ID: 8250604)
1. Concurrent ovarian serous carcinoma and osteogenesis imperfecta.
Nishida T; Oda T; Sugiyama T; Izumi S; Yakushiji M
Arch Gynecol Obstet; 1993; 253(3):153-6. PubMed ID: 8250604
[TBL] [Abstract][Full Text] [Related]
2. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-2004. A 52-year-old woman with postmenopausal bleeding and a cystic ovarian mass.
Penson RT; Sahani D; Bell DA
N Engl J Med; 2004 Dec; 351(24):2531-8. PubMed ID: 15590956
[No Abstract] [Full Text] [Related]
3. Serous psammocarcinoma of the ovary.
Powell JL; McDonald TJ; White WC
South Med J; 1998 May; 91(5):477-80. PubMed ID: 9598860
[TBL] [Abstract][Full Text] [Related]
4. Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient.
Moore MM; Tewari K; Rose GS; Fruehauf JP; DiSaia PJ
Gynecol Oncol; 1999 Jun; 73(3):452-4. PubMed ID: 10366478
[TBL] [Abstract][Full Text] [Related]
5. Borderline serous papillary tumor arising in a paraovarian cyst.
Terada T
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):215-6. PubMed ID: 20188456
[No Abstract] [Full Text] [Related]
6. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.
Ortiz BH; Ailawadi M; Colitti C; Muto MG; Deavers M; Silva EG; Berkowitz RS; Mok SC; Gershenson DM
Cancer Res; 2001 Oct; 61(19):7264-7. PubMed ID: 11585764
[TBL] [Abstract][Full Text] [Related]
7. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
[TBL] [Abstract][Full Text] [Related]
8. Renin-producing serous cystoadenocarcinoma of the ovary: a case report.
Iwamoto H; Hirata S; Honda T; Fukasawa H; Kimura N; Hoshi K
Eur J Gynaecol Oncol; 2002; 23(3):183-6. PubMed ID: 12094950
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
Tang L; Zheng M; Xiong Y; Ding H; Liu FY
Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
[TBL] [Abstract][Full Text] [Related]
10. Malignant mixed Mullerian tumor of broad ligament with synchronous ovarian and endometrial carcinoma: a rare association.
Arora P; Rao S; Khurana N; Talwar D; Tanwar R
J Cancer Res Ther; 2011; 7(1):88-91. PubMed ID: 21546752
[TBL] [Abstract][Full Text] [Related]
11. Minimal change disease in a patient with ovarian papillary serous carcinoma.
Ryu DR; Yoo TH; Kim YT; Jeong HJ; Cho NH; Kang SW
Gynecol Oncol; 2004 May; 93(2):554-6. PubMed ID: 15099980
[TBL] [Abstract][Full Text] [Related]
12. Morphologic criteria for the prognosis of serous cystadenocarcinoma of the ovary.
Geppert M; Smyczek-Gargya B
Gynecol Obstet Invest; 1995; 39(2):136-40. PubMed ID: 7737584
[TBL] [Abstract][Full Text] [Related]
13. Colonic carcinoma metastasis to ovary having serous cystadenocarcinoma -- an unusual case of double ovarian malignancy.
Visweswara RN; Prabhu VM
Cent Afr J Med; 1995 Nov; 41(11):357-9. PubMed ID: 8932579
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative radiation therapy for a patient with osteogenesis imperfecta: case report].
Ducournau A; Lagarde P; Henriques de Figueiredo B; Antoine M; Breton-Callu C; Petit A; Dallaudière B; Sargos P
Cancer Radiother; 2014 Mar; 18(2):132-5. PubMed ID: 24629322
[TBL] [Abstract][Full Text] [Related]
15. Endometriosis-associated serous borderline tumor and endometrial stromal sarcoma of the ovary: a report of a rare lesion in an infant.
Ho RS; Chan GC; Ha SY; Ip PP
Int J Gynecol Pathol; 2012 Jan; 31(1):98-102. PubMed ID: 22123729
[TBL] [Abstract][Full Text] [Related]
16. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study.
Barnhill DR; Kurman RJ; Brady MF; Omura GA; Yordan E; Given FT; Kucera PR; Roman LD
J Clin Oncol; 1995 Nov; 13(11):2752-6. PubMed ID: 7595734
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of prognostic factors for stage III ovarian epithelial carcinoma].
Wu M; Shen K; Lang JH; Huang RL; Huang HF; Pan LY
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1406-9. PubMed ID: 16029654
[TBL] [Abstract][Full Text] [Related]
18. Squash cytodiagnosis of synchronous papillary serous carcinoma of ovary and endometrium with demonstration of serous tubal intraepithelial carcinoma as a precursor lesion.
Kar A; Kar T; Dha I; Panda S
Indian J Pathol Microbiol; 2017; 60(1):125-127. PubMed ID: 28195111
[No Abstract] [Full Text] [Related]
19. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
[TBL] [Abstract][Full Text] [Related]
20. Serous papillary cystadenocarcinoma in supernumerary ovary.
Nomelini RS; Oliveira LJ; Jammal MP; Adad SJ; Murta EF
J Obstet Gynaecol; 2013 Apr; 33(3):324. PubMed ID: 23550880
[No Abstract] [Full Text] [Related]
[Next] [New Search]
